(Q45804571)

16 December 2017

title

Prolonged corrected QT interval in anti-Ro/SSA-positive adults with systemic lupus erythematosus (English)

1 reference

16 December 2017

4

Sasha Bernatsky

1 reference

16 December 2017

author name string

Josiane Bourré-Tessier

1

1 reference

16 December 2017

Ann E Clarke

2

1 reference

16 December 2017

Thao Huynh

3

1 reference

16 December 2017

Lawrence Joseph

5

1 reference

16 December 2017

Patrick Belisle

6

1 reference

16 December 2017

Christian A Pineau

7

1 reference

16 December 2017

publication date

1 July 2011

1 reference

16 December 2017

Arthritis Care and Research

published in

1 reference

16 December 2017

volume

63

1 reference

16 December 2017

issue

7

1 reference

16 December 2017

page(s)

1031-1037

1 reference

16 December 2017

QT Dispersion in rheumatoid arthritis patients with and without sj�gren's syndrome

cites work

1 reference

QT-interval parameters are increased in systemic lupus erythematosus patients.

21 January 2018

1 reference

Measurement of the QT interval and the risk associated with QTc interval prolongation: a review

21 January 2018

1 reference

The QT interval and cardiac arrhythmias

21 January 2018

1 reference

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

21 January 2018

1 reference

Perinatal outcome of fetal complete atrioventricular block: a multicenter experience

21 January 2018

1 reference

Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis

21 January 2018

1 reference

Neonatal lupus: basic research and clinical perspectives.

21 January 2018

1 reference

Direct inhibition of expressed cardiac l- and t-type calcium channels by igg from mothers whose children have congenital heart block

21 January 2018

1 reference

Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses

21 January 2018

1 reference

Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases

21 January 2018

1 reference

Arrhythmogenic effects of anti-Ro/SSA antibodies on the adult heart: more than expected?

21 January 2018

1 reference

Role of potassium currents in cardiac arrhythmias

21 January 2018

1 reference

Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects.

21 January 2018

1 reference

Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus

21 January 2018

1 reference

QTc: how long is too long?

21 January 2018

1 reference

Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation

21 January 2018

1 reference

Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies

21 January 2018

1 reference

Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients

21 January 2018

1 reference

Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ACR.20470

1 reference

16 December 2017

1 reference

16 December 2017